Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 06 04:00PM ET
22.68
Dollar change
+0.65
Percentage change
2.95
%
IndexRUT P/E- EPS (ttm)-5.48 Insider Own34.83% Shs Outstand29.65M Perf Week11.89%
Market Cap687.13M Forward P/E- EPS next Y-0.60 Insider Trans-0.09% Shs Float19.74M Perf Month10.47%
Income-163.43M PEG- EPS next Q-0.15 Inst Own50.58% Short Float3.43% Perf Quarter-7.58%
Sales290.70M P/S2.36 EPS this Y3.90% Inst Trans2.26% Short Ratio4.76 Perf Half Y6.63%
Book/sh37.42 P/B0.61 EPS next Y-53.52% ROA-12.64% Short Interest0.68M Perf Year-16.40%
Cash/sh10.29 P/C2.20 EPS next 5Y- ROE-13.66% 52W Range18.76 - 30.68 Perf YTD-21.55%
Dividend Est.- P/FCF58.73 EPS past 5Y-78.39% ROI-14.30% 52W High-26.08% Beta1.49
Dividend TTM- Quick Ratio5.27 Sales past 5Y258.65% Gross Margin36.38% 52W Low20.90% ATR (14)0.73
Dividend Ex-Date- Current Ratio5.27 EPS Y/Y TTM-233.61% Oper. Margin-24.55% RSI (14)69.93 Volatility4.68% 3.30%
Employees1184 Debt/Eq0.01 Sales Y/Y TTM-5.42% Profit Margin-56.22% Recom2.67 Target Price27.67
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q23.15% Payout- Rel Volume1.93 Prev Close22.03
Sales Surprise2.84% EPS Surprise150.22% Sales Q/Q4.68% EarningsNov 08 BMO Avg Volume142.19K Price22.68
SMA2011.67% SMA507.47% SMA2003.17% Trades Volume274,560 Change2.95%
Date Action Analyst Rating Change Price Target Change
Dec-07-23Initiated UBS Neutral $35
Dec-08-22Downgrade Piper Sandler Overweight → Neutral $65 → $40
Nov-18-22Initiated Raymond James Outperform $45
Aug-25-22Initiated Credit Suisse Outperform $65
Feb-04-22Resumed Piper Sandler Overweight $80
Aug-05-21Resumed Credit Suisse Underperform $55
Jan-08-21Downgrade Credit Suisse Neutral → Underperform $42 → $40
Nov-24-20Downgrade BTIG Research Buy → Neutral
Aug-20-20Initiated Oppenheimer Outperform $75
May-29-20Initiated BTIG Research Buy $20
Nov-05-24 08:00AM
Nov-01-24 08:08AM
Oct-31-24 08:00AM
Oct-17-24 04:05PM
Aug-13-24 12:00PM
09:55AM Loading…
09:55AM
Aug-02-24 08:15AM
07:00AM
Jul-18-24 04:36AM
Jul-11-24 04:05PM
Jun-10-24 01:00AM
Jun-03-24 08:00AM
May-24-24 08:00AM
May-15-24 04:21AM
May-14-24 04:05PM
09:00AM Loading…
09:00AM
May-04-24 09:15AM
03:04AM
May-03-24 10:46PM
11:53AM
08:34AM
08:15AM
07:00AM
Apr-11-24 04:05PM
Feb-29-24 09:31AM
Feb-28-24 10:18PM
07:35AM
07:00AM
Feb-13-24 08:00AM
Feb-09-24 08:31AM
09:45AM Loading…
Nov-25-23 09:45AM
Nov-14-23 04:30PM
Nov-05-23 09:02AM
Nov-03-23 10:26PM
04:05PM
08:52AM
08:45AM
07:00AM
Oct-30-23 03:46PM
Oct-25-23 08:00AM
Oct-18-23 09:44AM
Oct-17-23 08:00AM
Aug-05-23 08:56AM
Aug-04-23 10:08PM
08:15AM
07:00AM
Jul-24-23 04:05PM
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
08:20AM
May-18-23 04:05PM
May-08-23 11:15AM
09:40AM
May-05-23 08:15AM
07:00AM
Apr-26-23 08:00PM
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
06:49AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
Feb-28-23 08:25PM
04:05PM
04:03PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Feb-03-23 05:18AM
Jan-03-23 04:05PM
Dec-15-22 08:11AM
Dec-02-22 12:08PM
Nov-24-22 10:30AM
Nov-17-22 04:05PM
Nov-16-22 06:52AM
Nov-09-22 08:02AM
Nov-07-22 05:55PM
04:06PM
04:05PM
Oct-26-22 07:54AM
Oct-25-22 04:03PM
Oct-20-22 04:03PM
Oct-10-22 11:31AM
Aug-26-22 07:22AM
Aug-25-22 12:10PM
Aug-23-22 02:03PM
Aug-06-22 05:00AM
Aug-05-22 06:30AM
Aug-04-22 07:25PM
04:05PM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kim PaulCFO and TreasurerSep 03 '24Sale21.961,67436,763209,481Sep 05 04:21 PM
Xie JianPresident and COOSep 03 '24Sale21.961,59435,006341,170Sep 05 04:21 PM
Gao HanlinChief Scientific OfficerSep 03 '24Sale21.961,50333,007923,057Sep 05 04:20 PM
Xie Jian OfficerSep 03 '24Proposed Sale21.961,59435,006Sep 03 07:37 PM
Kim Paul OfficerSep 03 '24Proposed Sale21.961,67436,763Sep 03 07:36 PM
Gao HanlinChief Scientific OfficerAug 27 '24Sale22.8356312,855924,560Aug 29 06:34 PM
Xie JianPresident and COOAug 27 '24Sale22.8371516,326342,764Aug 29 06:33 PM
Hsieh MingChief Executive OfficerAug 27 '24Sale22.832,31352,813707,275Aug 29 06:33 PM
Kim PaulCFO and TreasurerAug 27 '24Sale22.8373316,737211,155Aug 29 06:33 PM
Hsieh Ming OwnerAug 27 '24Proposed Sale22.832,31352,813Aug 27 08:22 PM
Xie JianPresident and COODec 11 '23Sale26.5222,000583,453363,124Dec 13 08:49 PM
Xie JianPresident and COODec 04 '23Sale27.571,77949,053385,124Dec 06 06:00 PM
Kim PaulCFO and TreasurerDec 04 '23Sale27.571,43739,623200,460Dec 06 05:54 PM
Gao HanlinChief Scientific OfficerDec 04 '23Sale27.571,43739,623905,882Dec 06 05:47 PM
Xie JianPresident and COONov 16 '23Sale27.251,61744,065386,903Nov 20 04:30 PM
Kim PaulCFO and TreasurerNov 16 '23Sale27.251,30735,617201,897Nov 20 04:27 PM